Pozzilli Paolo (Paolo Pozzilli, P Pozzilli)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Venues

Diabetes/metabolism research and reviews

Diabetes, obesity & metabolism

Diabetes care

Diabetic medicine : a journal of the British Diabetic Association

European Medicines Agency

This page only lists publications with an associated author ORCID identifier.

Affiliation History

European Medicines Agency

United Kingdom

Rappresentante dell’Associazione Europea Studi sul Diabete (EASD) all’Agenzia Medica Europea di Londra (EMA)

Università Campus Bio-Medico di Roma

Italy

Coordinatore del Corso di Dottorato in Scienze Biomediche Integrate e Bioetica

Università Campus Bio-Medico di Roma

Italy

Nomina a delegato del rettore per le Relazioni Internazionali

Università Campus Bio-Medico di Roma

Italy

Nomina a Direttore del Dottorato di Ricerca Internazionale in Endocrinologia e Malattie Metaboliche

Università Campus Bio-Medico di Roma

Italy

2002 Nomina a Direttore Scuola Specializzazione di Endocrinologia

Università Campus Bio-Medico di Roma

Italy

Professore Straordinario :: Endocrinologia

Universita degli Studi di Roma Tor Vergata

Italy

2000 Docente di Fisiopatologia Endocrina Scuola di Specializzazione in Endocrinologia :: Endocrinologia

Queen Mary University of London

United Kingdom

Professor of Clinical Research :: Centre for Diabetes and Metabolic Medicine

Università Campus Bio-Medico di Roma

Italy

Professore Ordinario :: Endocrinologia e Diabetologia

Publications

Ernesto Maddaloni, Anda M Naciu, Carmen Mignogna, Raffaele Galiero, Rocco Amendolara, Marta Fogolari, Chiara Satta, Chiara Serafini, Silvia Angeletti, Maria Gisella Cavallo, Efisio Cossu, Ferdinando Carlo Sasso, Raffaella Buzzetti, Pozzilli Paolo, null null
Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study. Diabetes, obesity & metabolism (2024)
Ernesto Maddaloni, Anda M Naciu, Carmen Mignogna, Raffaele Galiero, Rocco Amendolara, Marta Fogolari, Chiara Satta, Chiara Serafini, Silvia Angeletti, Maria Gisella Cavallo, Efisio Cossu, Ferdinando Carlo Sasso, Raffaella Buzzetti, Pozzilli Paolo, null null
Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study. Diabetes, obesity & metabolism 26 (5) (2024)
Craig Sinclair Weston, Bernhard O Boehm, Pozzilli Paolo
Type 1 diabetes: A new vision of the disease based on endotypes. Diabetes/metabolism research and reviews 40 (2) (2024)
Ivy Lee Jia Jia, Raffaella Buzzetti, Richard David Leslie, Pozzilli Paolo
LADA 30th anniversary: A growing form of diabetes with persistent unresolved questions. Diabetes/metabolism research and reviews 40 (4) (2024)
Pozzilli Paolo
Chronicles of progress: Celebrating 40 years of scientific excellence in diabetes. Diabetes/metabolism research and reviews 40 (2) (2024)
Ernesto Maddaloni, Anda M Naciu, Carmen Mignogna, Raffaele Galiero, Rocco Amendolara, Marta Fogolari, Chiara Satta, Chiara Serafini, Silvia Angeletti, Maria Gisella Cavallo, Efisio Cossu, Ferdinando Carlo Sasso, Raffaella Buzzetti, Pozzilli Paolo, null null
Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study. Diabetes, obesity & metabolism 26 (5) (2024)
Felecia D'Souza, Raffaella Buzzetti, Pozzilli Paolo
Diabetes, COVID-19, and questions unsolved. Diabetes/metabolism research and reviews (2023)
Pozzilli Paolo
What does publishing a paper mean for you? Diabetes/metabolism research and reviews (2023)
Pozzilli Paolo
What does publishing a paper mean for you? Diabetes/metabolism research and reviews (2023)
Ernesto Maddaloni, Angela Carlone, Dario Pitocco, Giulia Leanza, Concetta Suraci, Maria Altomare, Maria G Cavallo, Ilaria Barchetta, Susanna Morano, Chiara Moretti, Lucia Coraggio, Natalia Visalli, Flavia Tramontana, Riccardo Schiaffini, Antonino Crinò, Raffaella Buzzetti, Pozzilli Paolo, null null
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study. Diabetes, obesity & metabolism 25 (11) (2023)
Silvia Pieralice, Luca D'Onofrio, Pozzilli Paolo, Raffaella Buzzetti
Third dose of COVID-19 vaccine in diabetes: Relevance of good metabolic control to improve its efficacy. Diabetes/metabolism research and reviews 38 (5) (2022)
Francesca De Ridder, Kristien J Ledeganck, Benedicte Y De Winter, Rie Braspenning, Danaë Delbeke, Pr Eric Renard, Pozzilli Paolo, Silvia Pieralice, Dirk Vissers, Christophe E M De Block
Trends of glucose, lactate and ketones during anaerobic and aerobic exercise in subjects with type 1 diabetes: The ACTION-1 study. Diabetes/metabolism research and reviews 38 (6) (2022)
Riccardo Pofi, Elisa Giannetta, Tiziana Feola, Nicola Galea, Federica Barbagallo, Federica Campolo, Roberto Badagliacca, Biagio Barbano, Federica Ciolina, Giuseppe Defeudis, Tiziana Filardi, Franz Sesti, Marianna Minnetti, Carmine Dario Vizza, Patrizio Pasqualetti, Pierluigi Caboni, Iacopo Carbone, Marco Francone, Carlo Catalano, Pozzilli Paolo, Andrea Lenzi, Mary Anna Venneri, Daniele Gianfrilli, Andrea M Isidori
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial. Science translational medicine 14 (649) (2022)
Ernesto Maddaloni, Geremia B Bolli, Brian M Frier, Randie R Little, Richard D Leslie, Pozzilli Paolo, Raffaella Buzzetti
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective. Diabetes, obesity & metabolism 24 (10) (2022)
Lorenzo Piemonti, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, Pozzilli Paolo, Francesco Giorgino, Efisio Cossu, Luisa Daffonchio, Giovanni Goisis, Pier Adelchi Ruffini, Anna Rita Maurizi, Flavio Mantelli, Marcello Allegretti
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial. Diabetes, obesity & metabolism 24 (9) (2022)
Catriona Chaplin, Pozzilli Paolo
SARS-CoV-2 induced post-translational protein modifications: A trigger for developing autoimmune diabetes? Diabetes/metabolism research and reviews 38 (1) (2022)
Ghadeer E Alhamar, Ernesto Maddaloni, Abdullah Al Shukry, Salman Al-Sabah, Mohannad Al-Haddad, Sarah Al-Youha, Mohammed Jamal, Sulaiman Almazeedi, Abdullah A Al-Shammari, Mohamed Abu-Farha, Jehad Abubaker, Abdulnabi T Alattar, Ebaa AlOzairi, Francesco Alessandri, Luca D'Onofrio, Gaetano Leto, Carlo Maria Mastroianni, Carmen Mignogna, Giuseppe Pascarella, Francesco Pugliese, Hamad Ali, Fahd Al Mulla, Raffaella Buzzetti, Pozzilli Paolo
Development of a clinical risk score to predict death in patients with COVID-19. Diabetes/metabolism research and reviews 38 (5) (2022)
Roberto Cesareo, Silvia Manfrini, Valerio Pasqualini, Cesare Ambrogi, Gianfranco Sanson, Andrea Gallo, Pozzilli Paolo, Claudio Pedone, Anna Crescenzi, Andrea Palermo
Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study). The Journal of clinical endocrinology and metabolism 106 (6) (2021)
Giuseppe Defeudis, Rossella Mazzilli, Marta Tenuta, Giovanni Rossini, Virginia Zamponi, Soraya Olana, Antongiulio Faggiano, Pozzilli Paolo, Andrea M Isidori, Daniele Gianfrilli
Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes/metabolism research and reviews (2021)
Ghadeer E Alhamar, Rocky Strollo, Pozzilli Paolo
Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive Individuals. Diabetes Care 2020;43:913-917. Diabetes care 43 (8) (2021)
Tuccinardi Dario, Antonio Di Mauro, Greta Lattanzi, Giovanni Rossini, Lavinia Monte, Ivan Beato, Chiara Spiezia, Maria Bravo, Mikiko Watanabe, Andreea Soare, Shadi Kyanvash, Andrea Armirotti, Sine Mandrup Bertozzi, Amalia Gastaldelli, Claudio Pedone, Yeganeh Manon Khazrai, Pozzilli Paolo, Silvia Manfrini
An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial. Diabetes/metabolism research and reviews (2021)
Pozzilli Paolo, L Nicolai
Cosimo I de Medici and his Merseburg triad of Graves' disease. Journal of endocrinological investigation 44 (12) (2021)
Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Pozzilli Paolo
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes. Diabetes/metabolism research and reviews 37 (6) (2020)
Ernesto Maddaloni, Chiara Moretti, Rossella Del Toro, Sara Sterpetti, Maria Vittoria Ievolella, Gabriele Arnesano, Rocky Strollo, Silvia Irina Briganti, Luca D'Onofrio, Pozzilli Paolo, Raffaella Buzzetti
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study. Diabetic medicine : a journal of the British Diabetic Association 38 (2) (2020)
Francesca Cannata, Gianluca Vadalà, Fabrizio Russo, Rocco Papalia, Nicola Napoli, Pozzilli Paolo
Beneficial Effects of Physical Activity in Diabetic Patients. Journal of functional morphology and kinesiology 5 (3) (2020)
Tuccinardi Dario, Giorgino Riccardo, Pieralice Silvia, Watanabe Mikiko, Maggi Daria, Palermo Andrea, Defeudis Giuseppe, Fioriti Elvira, Pozzilli Paolo, Manfrini Silvia
The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study. Acta diabetologica 58 (4) (2020)
Francesca Cannata, Gianluca Vadalà, Luca Ambrosio, Nicola Napoli, Rocco Papalia, Vincenzo Denaro, Pozzilli Paolo
The impact of type 2 diabetes on the development of tendinopathy. Diabetes/metabolism research and reviews 37 (6) (2020)
Ernesto Maddaloni, Lucia Coraggio, Silvia Pieralice, Angela Carlone, Pozzilli Paolo, Raffaella Buzzetti
Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy. Diabetes care 43 (8) (2020)
Raffaella Buzzetti, Tiinamaija Tuomi, Esmeralda Castelblanco, Massimo Pietropaolo, Zhiguang Zhou, Pozzilli Paolo, Richard David Leslie
Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes 69 (10) (2020)
Rocky Strollo, Pozzilli Paolo
DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19? Diabetes/metabolism research and reviews 36 (8) (2020)
Sofia Battisti, Claudio Pedone, Nicola Napoli, Emanuele Russo, Vanni Agnoletti, Stefano Geniere Nigra, Caterina Dengo, Martina Mughetti, Caterina Conte, Pozzilli Paolo, Emanuela Giampalma, Rocky Strollo
Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19. Diabetes care 43 (10) (2020)
Mahmoud Ibrahim, Jason Baker, Avivit Cahn, Robert H Eckel, Nuha Ali El Sayed, Amy Hess Fischl, Peter Gaede, R David Leslie, Silvia Pieralice, Dario Tuccinardi, Pozzilli Paolo, Bjørn Richelsen, Eytan Roitman, Eberhard Standl, Yoel Toledano, Jaakko Tuomilehto, Sandra L Weber, Guillermo E Umpierrez
Hypoglycaemia and its management in primary care setting. Diabetes/metabolism research and reviews 36 (8) (2020)
Raffaella Buzzetti, Simona Zampetti, Pozzilli Paolo
Impact of obesity on the increasing incidence of type 1 diabetes. Diabetes, obesity & metabolism 22 (7) (2020)
Francesca Cannata, Gianluca Vadalà, Luca Ambrosio, Sara Fallucca, Nicola Napoli, Rocco Papalia, Pozzilli Paolo, Vincenzo Denaro
Intervertebral disc degeneration: A focus on obesity and type 2 diabetes. Diabetes/metabolism research and reviews 36 (1) (2019)
Rocky Strollo, Chiara Vinci, Nicola Napoli, Elvira Fioriti, Ernesto Maddaloni, Linda Åkerman, Rosaura Casas, Pozzilli Paolo, Johnny Ludvigsson, Ahuva Nissim
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies. Diabetes/metabolism research and reviews 35 (4) (2019)
Francesca Cannata, Gianluca Vadalà, Luca Ambrosio, Nicola Napoli, Rocco Papalia, Vincenzo Denaro, Pozzilli Paolo
Osteoarthritis and type 2 diabetes: From pathogenetic factors to therapeutic intervention. Diabetes/metabolism research and reviews 36 (3) (2019)
Mahmoud Ibrahim, Jaakko Tuomilehto, Pablo Aschner, Lucille Beseler, Avivit Cahn, Robert H Eckel, Amy Hess Fischl, George Guthrie, James O Hill, Mick Kumwenda, R David Leslie, Darin E Olson, Pozzilli Paolo, Sandra L Weber, Guillermo E Umpierrez
Global status of diabetes prevention and prospects for action: A consensus statement. Diabetes/metabolism research and reviews 34 (6) (2018)
Annunziata Nusca, Dario Tuccinardi, Marzia Albano, Camilla Cavallaro, Elisabetta Ricottini, Silvia Manfrini, Pozzilli Paolo, Germano Di Sciascio
Glycemic variability in the development of cardiovascular complications in diabetes. Diabetes/metabolism research and reviews 34 (8) (2018)
Sara Quercia, Silvia Turroni, Jessica Fiori, Matteo Soverini, Simone Rampelli, Elena Biagi, Andrea Castagnetti, Clarissa Consolandi, Marco Severgnini, Mario Pianesi, Francesco Fallucca, Pozzilli Paolo, Patrizia Brigidi, Marco Candela
Gut microbiome response to short-term dietary interventions in reactive hypoglycemia subjects. Diabetes/metabolism research and reviews 33 (8) (2017)
C Guglielmi, R Del Toro, A Lauria, A R Maurizi, S Fallucca, A Cappelli, S Angeletti, J M Lachin, Pozzilli Paolo
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes. Diabetes/metabolism research and reviews 33 (6) (2017)

Pozzilli Paolo.css-eqlu8i{font-size:small;padding-left:4px;} (Paolo Pozzilli, P Pozzilli)

Publication Activity (10 Years)

Top Topics

Top Venues

Pozzilli Paolo (Paolo Pozzilli, P Pozzilli)